BioAtla, Inc. (BCAB) stock
BCABOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$1.31−0.05 (-3.68%)
Close on Oct 19, 2026Market cap $2.18MP/E –Yield –
BioAtla operating margin
Operating margin is operating income as a percentage of revenue.
BioAtla's operating margin for the twelve months ending Mar 31, 2022 was -33996.3%. For fiscal 2021 it was -32146.7%.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | -32146.7% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2021 | Jun 30, 2021 | -10153.3% | – |
See a number that looks wrong?